Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.415
-0.395 (-8.21%)
Mar 31, 2025, 1:31 PM EDT - Market open
Y-mAbs Therapeutics Employees
Y-mAbs Therapeutics had 104 employees as of December 31, 2024. The number of employees increased by 4 or 4.00% compared to the previous year.
Employees
104
Change (1Y)
4
Growth (1Y)
4.00%
Revenue / Employee
$843,125
Profits / Employee
-$285,250
Market Cap
199.64M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
YMAB News
- 26 days ago - Y-mAbs Therapeutics, Inc. (YMAB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Y-mAbs Reports Fourth Quarter 2024 Financial Results and Recent Corporate Developments - GlobeNewsWire
- 4 weeks ago - Y-mAbs Announces Publication of Phase 2 Interim Results in Nature Communications - GlobeNewsWire
- 5 weeks ago - Y-mAbs to Announce Fourth Quarter and Full Year 2024 Financial and Operating Results on March 4, 2025 - GlobeNewsWire
- 7 weeks ago - Y-mAbs to Present at the Oppenheimer 35ᵗʰ Annual Life Sciences Conference - GlobeNewsWire
- 2 months ago - Y-mAbs Presents Translational Pharmacokinetics of GD2-SADA from Pretargeted RIT Platform at the SNMMI Mid-Winter and ACNM Annual Meeting - GlobeNewsWire
- 2 months ago - Y-mAbs Therapeutics: Finding Direction Through The Murk Of Clinical Trials - Seeking Alpha
- 2 months ago - Correcting & Replacing – Y-mAbs Provides Strategic Business Update and 2025 Priorities - GlobeNewsWire